Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia.

ABSTRACT:

Aim

Continued antipsychotic treatment is the key to preventing relapse. Maintenance antipsychotic monotherapy and optimal dose use are recommended for individuals with stable schizophrenia because of their undesirable effects. Decision aids (DAs) are clinical conversation tools that facilitate shared decision-making (SDM) between patients and health-care providers. This study aimed to describe the development process and results of acceptability testing of a DA for individuals with stable schizophrenia, considering (i) whether to continue high-dose antipsychotics or reduce to the standard dose and (ii) whether to continue two antipsychotics or shift to monotherapy.

Methods

A DA was developed according to the guidelines for the appropriate use of psychotropic medications and

SUBMITTER: Aoki Y 

PROVIDER: S-EPMC10496039 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature